Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users

NCT05053126 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Abuse Potential

Interventions

DRUG: Pregabalin 300mg
DRUG: pregabalin 450 mg
DRUG: Pregabalin 300 mg with oxycodone 20 mg
DRUG: pregabalin 450 mg with oxycodone 20 mg
DRUG: oxycodone 20 mg
DRUG: Placebo

Sponsor

Viatris Specialty LLC